Alcon Inc. (ALC)

Market Cap	42.13B
Revenue (ttm)	9.76B
Net Income (ttm)	1.16B
Shares Out	494.60M
EPS (ttm)	2.34
PE Ratio	36.29
Forward PE	26.39
Dividend	$0.26 (0.31%)
Ex-Dividend Date	May 14, 2024

Volume	574,012
Open	85.46
Previous Close	85.43
Day's Range	85.01 - 85.67
52-Week Range	71.46 - 101.10
Beta	0.73
Analysts	Strong Buy
Price Target	102.12 (+19.44%)
Earnings Date	Nov 12, 2024

About ALC

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company’s Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic mi...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1945
• Employees: 25,315
• Stock Exchange: NYSE
• Ticker Symbol: ALC
• Website: https://www.alcon.com

Financial Performance

In 2023, Alcon's revenue was $9.46 billion, an increase of 8.47% compared to the previous year's $8.72 billion. Earnings were $974.00 million, an increase of 190.75%.

Analyst Forecast

According to 14 analysts, the average rating for ALC stock is "Strong Buy." The 12-month stock price forecast is $102.12, which is an increase of 19.44% from the latest price.

Price Target

$102.12

(19.44% upside)

Analyst Consensus: Strong Buy